Liege, Belgium – 3 September 2025 (08:30) – Allegro NV, a biomedical company developing transformative devices for degenerative joint disease, has appointed […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 3 […]
Liege, Belgium – 11 April 2025 (17:00 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for osteoarthritis, today presented […]
Liege, Belgium – 25 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for osteoarthritis, has found […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 4 […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 11 […]